epithalon dosage human studies EPITALON Peptide Therapy in Connecticut The Peptide Craze - Ground

Many reputable peptide suppliers formulate their flagship products in this range

Research has shown that GHK Cu: Downregulates TGF-beta1 (the primary pro-fibrotic cytokine) in fibrotic cell models Upregulates decorin a proteoglycan that inhibits TGF-beta1 signalling and organises collagen fibril structure Reduces expression of MMP inhibitors, allowing physiological matrix remodelling to proceed This dual action promoting organised collagen synthesis in healing wounds while suppressing dysregulated fibrotic collagen makes GHK Cu of interest in research models of skin fibrosis, liver fibrosis, and lung fibrosis

doi: 10.3233/JAD-142814

While public statements do not instantly change federal law, this potential regulatory shift has sparked widespread excitement about the future of physician-led peptide therapies

Submit a Testimonial